At UCB, everything we do starts with one simple question: “How will this make a difference in the lives of people living with severe diseases?” This question is our motivation, inspiration and what challenges us to stay focused on what will ultimately benefit the patients we serve. Read more from Camille Lee, Head of U.S. Immunology, about how UCB is working to empower patients impacted by immuno-dermatological conditions.

Congratulations to Andrea Loewendorf – Head, Market Access and Innovation Strategy, Neurology and Jessica Williamson, PhD – Protein Production Lead for their recognition as a Healthcare Businesswomen's Association (HBA) Rising Stars for 2020!

At UCB, we are using our passion and expertise to address gaps in post-fracture care to provide patients the support they need. This Osteoporosis Awareness Month, read from Alison Kocanda, Head of U.S. Bone, as she shares how UCB is supporting patients through education and resources.

Every three seconds - that is how often it is estimated that a fragility fracture occurs. Although nearly 9 million fractures occur annually worldwide, oftentimes people think fragile bones are an inevitable part of getting older, but a fracture may more commonly be the result of an underlying condition: osteoporosis. This May for Osteoporosis Awareness Month, we’re highlighting things to know about osteoporosis and our commitment to addressing the gaps impacting those living with the disease.

Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.

Developing impactful and innovative solutions for patients whose lives have been challenged by severe diseases is our focus at UCB. This Arthritis Awareness Month, learn more about psoriatic arthritis (PsA), one of the many types of arthritic disease.

Serving others is in our DNA at UCB – from committing to patients in our daily jobs to finding ways to make a difference in our communities through volunteerism. Each year, UCB employees get 32-hours of time off to volunteer their time at non-profits of their choice, and COVID-19 has not slowed us down from using those hours to help others during this difficult time. This National Volunteer Week, we’re celebrating our employees, whose selfless efforts during this COVID-19 pandemic inspire us.

During the COVID-19 pandemic, we’re reminded of the many challenges facing our world. At UCB, we recognize the challenges facing the world, from climate change to rising inequalities, are inextricably linked and that businesses have a key role to play to ensure a sustainable future for all. This Earth Day, we’re highlighting some of our progress as it relates to minimizing our environmental footprint across the value chain.

With the U.S. heavily impacted by the novel coronavirus, COVID-19, UCB is committed to playing our part to contribute our scientific expertise and resources to the greater response effort happening across the country and the world. This includes expanding our assistance programs to further help patients impacted by the pandemic.

The emergency department is a common point of medical intervention for epilepsy patients. We recognize there are more than one million visits to the emergency department every year for epilepsy-related seizures . These visits are not only a significant cost to the healthcare system, but also often leave patients with questions and unease related to their epilepsy diagnosis. The Centers for Disease Control and Prevention (CDC) has also recognized epilepsy as a public health challenge where patients need more skills and resources to manage their condition effectively. That’s why UCB Inc. is working with Indiana University School of Nursing to address existing gaps in care when it comes to emergency department visits and epilepsy care.